Welcome to our dedicated page for Ingersoll Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingersoll Rand Inc. filings document financial results, material events, governance actions and shareholder voting matters for a NYSE-listed industrial operating company. Form 8-K reports furnish quarterly and annual operating results, liquidity information, non-GAAP reconciliations and Regulation FD disclosures tied to company announcements.
Proxy materials cover annual meeting procedures, director elections, board committee structure, executive and director compensation, stockholder voting mechanics and governance practices. Additional 8-K filings record board size changes, independent director appointments, committee assignments and related capital-structure or governance disclosures.
Ingersoll Rand Inc. reported that officer Andrew R. Schiesl sold 18,000 shares of common stock in an open-market transaction on February 17, 2026 at $98.00 per share. After this sale, he directly owned 11,405 Ingersoll Rand common shares.
IR submitted a Form 144 notice reporting a proposed sale of 4,300 common shares through Fidelity Brokerage Services LLC on 02/19/2026 for trading on the NYSE. The filing also lists restricted stock vesting events of 846 shares on 02/22/2023 and 3,454 shares on 02/23/2024, each noted as issuer compensation.
Ingersoll Rand Inc. insider Vicente Reynal reported multiple equity transactions. On February 17, 2026, he sold 36,482 shares of common stock in an open-market transaction at $97.50 per share, leaving 193,186 shares held directly afterward.
On February 13, 2026, he exercised fully vested stock options for 55,870 shares at an exercise price of $10.61 per share and sold the same 55,870 shares of common stock in an open-market sale at a weighted average price of $100.39, with individual trades ranging from $100.00 to $100.96. The February 13 sales were executed under a pre‑arranged Rule 10b5‑1 trading plan adopted on May 22, 2025.
In addition to his direct holdings, Reynal is reported as having indirect ownership of common stock through three trusts holding 147,802, 75,000, and 22,500 shares, respectively, for the benefit of himself, his spouse, and his descendants.
Vicente Reynal reported a notice to sell 900 common shares under an issuer option on 02/18/2026. The filing lists multiple recent open-market dispositions by Mr. Reynal during the past three months, including 191,000 on 01/16/2026 and several sales in February 2026 with proceeds shown.
Ingersoll Rand Inc. is a global industrial company focused on mission-critical flow creation, with compressors, pumps, vacuum and blower products sold under more than 90 brands across diverse end markets such as life sciences, food and beverage, clean energy, and water treatment.
The business is organized into two segments: Industrial Technologies and Services, and Precision and Science Technologies. Aftermarket parts, consumables and services are a major driver, representing 36.5% of total revenue in 2025, providing a recurring revenue base from its large installed equipment fleet.
In 2025 the company pursued inorganic growth, acquiring SSI Aeration for $97.8 million and TMIC/Adicomp for $193.2 million to deepen exposure to wastewater treatment and renewable natural gas. Capital allocation also included $1,018.0 million of share repurchases and $31.8 million of dividends on common stock.
Ingersoll Rand employed over 21,000 people as of December 31, 2025, emphasizes employee ownership and engagement, and reports strong survey scores. The company highlights extensive global operations, exposure to non-U.S. markets, and detailed risk factors spanning macroeconomic conditions, supply chain, technology, AI, ESG and cybersecurity.
An investor in IR common stock has filed a notice of proposed sale under Rule 144 to dispose of 12,000 common shares through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of February 17, 2026 and an aggregate market value of 1,193,520.00. The filing notes that 395,110,395 common shares were outstanding. These shares were acquired over time through restricted stock vesting from the issuer as compensation between March 25, 2021 and February 6, 2026, including grants such as 5,973 shares vested on February 10, 2025 and 2,243 shares vested on February 6, 2026. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
An insider associated with IR has filed a notice of intent to sell 36,482 shares of common stock through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 02/17/2026. These shares were acquired on 02/06/2026 via restricted stock vesting as compensation.
The filing also lists recent selling activity over the prior three months by Vicente Reynal, including separate sales of 191,000, 9,719, 90,281, 440, and 55,870 common shares, with reported gross proceeds for each transaction.
IR filed a Form 144 indicating a planned resale of common stock by shareholder Mike Scheske. The notice covers 19,122 shares of common stock, with an aggregate market value of 1,867,561.19, to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/17/2026.
The filing states that 395,110,395 shares of the issuer’s common stock were outstanding. It also notes that the same seller disposed of 1,477 common shares during the past three months for gross proceeds of 119,085.93.
A holder of restricted Common shares has filed a Rule 144 notice to sell 18246 shares through Fidelity Brokerage Services on 02/17/2026 on the NYSE. The filing lists an aggregate market value of 1771869.06 for the planned sale.
The shares were acquired on 02/17/2026 by exercising an option originally granted on 08/09/2021, paid in cash. The issuer reports 395110395 shares of this class outstanding, giving context for the size of the planned transaction.
IR has a Rule 144 notice indicating a planned sale of 18,000 shares of its common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 1,764,000.00 and an approximate sale date of 02/17/2026.
Shares outstanding were 395,110,395 as of the notice; this is a baseline figure, not the amount being sold. The shares to be sold were acquired from the issuer via stock option exercises on 05/17/2024 and 08/08/2024 and restricted stock vesting on 02/06/2026, using cash for option exercises and compensation for the restricted stock.